Page last updated: 2024-10-14

docosahexaenoyl-paclitaxel

Description

docosahexaenoyl-paclitaxel: an antineoplastic agent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918473
CHEMBL ID4297441
SCHEMBL ID10000714
MeSH IDM0520405

Synonyms (22)

Synonym
taxoprexin
dha-paclitaxel
docosahexaenoyl-paclitaxel
dha paclitaxel
docosahexaenoic acid-paclitaxel
199796-52-6
oje5810c4f ,
unii-oje5810c4f
paclitaxel 2'-(all-cis-4,7,10,13,16,19-docosahexaenoate)
paclitaxel-dha
dha paclitaxel [who-dd]
DB05297
paclitaxel docosahexaenoic acid
paclitaxel docosahexaenoic acid ester
SCHEMBL10000714
DTXSID00873216
Q5205001
(2ar,4s,4as,6r,9s,11s,12s,12bs)-9-(((2r,3s)-3-benzamido-2-((4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoyloxy)-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1h-7,11
[(1s,2s,3r,4s,7r,9s,10s,12r,15s)-4,12-diacetyloxy-15-[(2r,3s)-3-benzamido-2-[(4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2
CHEMBL4297441
HY-105071
CS-0024881
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (80.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other1 (20.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]